(Q45748000)

English

The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma

scientific article published on 30 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Isil Z Yildiz-Aktas

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

David J Dabbs

2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

Rohit Bhargava

3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

publication date

30 March 2012

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

Modern Pathology

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

25

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

8

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

1098-1105

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.59

0 references

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Histopathologic variables predict Oncotype DX recurrence score

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Delay to formalin fixation effect on breast biomarkers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Effect of ischemic time, fixation time, and fixative type on HER2/neu immunohistochemical and fluorescence in situ hybridization results in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

21 January 2018

Treatment of primary breast cancer with chemotherapy and tamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and dynamic localisation of estradiol-receptor complexes in intact target cells by immunofluorescence technique

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of delay in fixation, different fixatives, and duration of fixation in estrogen and progesterone receptor results in breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.59

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2012.59

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/22460807

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45748000&oldid=2080919167"